Treatment goals for panic disorder

Journal of Clinical Psychopharmacology

Volumn 18, Issue 6 SUPPL. 2, 1998, Pages

  Starcevic, Vladan ^a,b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Institute of Mental Health   (Yugoslavia)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DEPRESSION; DRUG EFFICACY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PANIC; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; TREATMENT PLANNING;

EID: 0031763016     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199812001-00005     Document Type: Conference Paper

References (38)

1. Faravelli C, Paterniti S, Scarpato A. 5-year prospective, naturalistic follow-up study of panic disorder. Compr Psychiatry 1995; 36:271-7.
2. Katschnig H, Amering M, Stolk JM, Klerman GL, Ballenger JC, Briggs A, Buller R, Cassano G, Garvey M, Roth M, Solyom C. Long-term follow-up after a drug trial for panic disorder. Br J Psychiatry 1995;167:487-94.
3. Cowley DS, Flick SN, Roy-Byrne PP. Long-term course and outcome in panic disorder: a naturalistic follow-up study. Anxiety 1996;2:13-21.
4. O'Rourke D, Fahy TJ, Brophy J, Prescott P. The Galway study of panic disorder III: outcome at 5 to 6 years. Br J Psychiatry 1996;168:462-9.
5. Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R Jr, DuPont RL Jr. Secondary depression in panic disorder and agoraphobia: I. frequency, severity, and response to treatment. Arch Gen Psychiatry 1988;45:437-43.
6. Markowitz JS, Weissman MM, Ouellette R, Lish JD, Klerman GL. Quality of life in panic disorder. Arch Gen Psychiatry 1989; 46:984-92.
7. Sherbourne CD, Wells KB, Judd LL. Functioning and well-being of patients with panic disorder. Am J Psychiatry 1996;153:213-8.
8. Katerndahl DA, Realini JP. Quality of life and panic-related work disability in subjects with infrequent panic and panic disorder. J Clin Psychiatry 1997;58:153-8.
9. Roy-Byrne PP, Cowley DS. Course and outcome in panic disorder: a review of recent follow-up studies. Anxiety 1994;1:151-60.
10. Salvador-Carulla L, Segui J, Fernandez-Cano P, Canet J. Costs and offset effect in panic disorders. Br J Psychiatry 1995;166[suppl 27]:23-8.
11. DuPont RL, Rice DP, Miller LS, Shiraki SS, Rowland CR, Harwood HJ. Economic costs of anxiety disorders. Anxiety 1996;2:167-72.
12. Leon AC, Olfson M, Portera L. Service utilization and expenditures for the treatment of panic disorder. Gen Hosp Psychiatry 1997;19:82-8.
13. Clark LA, Watson D, Mineka S. Temperament, personality, and the mood and anxiety disorders. J Abnorm Psychol 1994;103: 103-16.
14. Hazen AL, Walker JR, Eldridge GD. Anxiety sensitivity and treatment outcome in panic disorder. Anxiety 1996;2:34-9.
15. Muskin PR, Fyer AJ. Treatment of panic disorder. J Clin Psychopharmacol 1981;1:81-90.
16. Mavissakalian M, Perel JM. Imipramine in panic disorder with agoraphobia; dose-ranging and plasma level-response relationships. Am J Psychiatry 1995;152:673-82.
17. Zoellner LA, Craske MG, Rapee RM. Stability of catastrophic cognitions in panic disorder. Behav Res Ther 1996;34:399-402.
18. Albus M, Scheibe G, Scherer J. Fluctuations of symptoms and social functioning in panic disorder with or without concomitant depression: a 5-year prospective follow-up. Psychopathology 1995;28:229-34.
19. Fava GA, Zielezny M, Savron G, Grandi S. Long-term effects of behavioural treatment for panic disorder with agoraphobia. Br J Psychiatry 1995;166:87-92.
20. O'Sullivan G, Marks IM. Long-term outcome of phobic and obsessive-compulsive disorders after treatment. In: Noyes R, Burrows GD, Roth M, eds. Handbook of anxiety. Vol 4. Amsterdam: Elsevier, 1991:87-108.
21. Brown TA, Barlow DH. Long-term outcome in cognitive-behavioral treatment of panic disorder clinical predictors and alternative strategies for assessment. J Consult Clin Psychol 1995; 63:754-65.
22. Shear MK, Maser JD. Standardized assessment for panic disorder research: a conference report. Arch Gen Psychiatry 1994;51: 346-54.
23. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
24. Telch MJ. The Panic Appraisal Inventory. Austin: University of Texas, 1987.
25. Telch MJ, Brouillard M, Telch CF, Acrac WS, Taylor CB. Role of cognitive appraisal in panic-related avoidance. Behav Res Ther 1989;27:373-83.
26. Marks IM, Mathews AM. Brief standard self-rating for phobic patients. Behav Res Ther 1979;17:263-7.
27. Sheehan DV. Target 1: biological. In: The anxiety disease. New York: Charles Scribner's and Sons, 1983:118-42.
28. Leon AC, Shear MK, Portera L, Klerman GL. Assessing impairment in patients with panic disorder: the Sheehan Disability Scale. Soc Psychiatry Psychiatr Epidemiol 1992;27:78-82.
29. Cloninger CR, Przybeck TR, Svrakic DM. The Tridimensional Personality Questionnaire: U.S. normative data. Psychol Rep 1995; 69:1047-57.
30. Eysenck HJ, Eysenck SBG. Manual of the Eysenck Personality Inventory. Kent, England: Hodder and Stoughton, 1964.
31. Andrews G, Pollock C, Stewart G. The determination of defense style by questionnaire. Arch Gen Psychiatry 1989;46:455-60.
32. Craig AR, Franklin JA, Andrews G. A scale to measure locus of control of behaviour. Br J Med Psychol 1984;57:173-80.
33. Starcevic V, Bogojevic G. Integrative therapy of agoraphobia with panic disorder - theoretical basis, application and results. Psychiatry Today 1996;28:271-91.
34. Starcevic V, Bogojevic G. The long-term efficacy and cost of integrative treatment of agoraphobia with panic disorder in the day clinic [programme and abstracts: 21]. In: Mental health policy and economics. Health care reform and research in central and eastern Europe. 1997 September 6-7; Budapest, Hungary.
35. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4: 561-71.
36. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100.
37. Lipman RS, Covi L, Shapiro AK. The Hopkins Symptom Checklist (HSCL): factors derived from the HSCL-90. J Affect Disord 1979; 1:9-24.
38. Guy W. Early Clinical Drug Evaluation Unit (ECDEU). Rockville, MD: National Institute of Mental Health; 1976. U.S. Department of Health, Education, and Welfare Publication (ADM)76-338.